在CKDN2A基因型患者中,第一个黑色素瘤和第一个非皮肤瘤之间的时间相关性
Laura Cristina Gironi1, Elia Esposto1, Francesca Zottarelli1
1Dermatology Unit, AOU Maggiore della Carità.
Melanoma research
|June 23, 2023
概括
患有CDKN2A致病变体和黑色素瘤的患者需要对非皮肤瘤 (NCTs) 进行全面监测. 黑色素瘤的诊断往往在突变载体和野生类型个体中都比NCT的发展早几年.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 皮肤病学 皮肤病学
背景情况:
- CDKN2A致病变体与皮肤黑色素瘤和非皮肤瘤 (NCT) 有关.
- 皮肤黑色素瘤和CDKN2A突变携带者与野生型患者的NCT发展之间的时间关系尚不清楚.
- 了解这个时间表对于有效的患者监测至关重要.
研究的目的:
- 调查第一次皮肤黑色素瘤和NCT诊断之间的时间相关性.
- 为了比较CDKN2A突变载体 (MUT) 与野生型黑色素瘤患者的时间表.
- 为黑色素瘤患者的监测策略提供信息.
主要方法:
- 在245名皮肤黑色素瘤患者中对CDKN2A基因进行基因定型.
- 将患者分为CDKN2A突变携带者 (MUT) 和野生型组.
- 分析第一次皮肤黑色素瘤诊断和第一次NCT诊断 (恶性或良性) 之间的时间间隔.
主要成果:
- 与野生型患者相比,MUT患者的皮肤黑色素瘤发病率更高.
- 两组中13.7%的人被诊断出至少有一种恶性NCT,没有显著差异.
- 皮肤黑色素瘤发病前的NCT发病平均为MUT的4.5年和野生型患者的3.02年.
- 黑色素瘤诊断在恶性NCT诊断之前平均为MUT的8年和野生型患者的4.34年.
结论:
- 在皮肤黑色素瘤和随后的NCT发展之间存在显著的时间差距.
- 皮肤黑色素瘤患者,无论CDKN2A状态如何,都需要对NCTs进行终身监测.
- 建议采用全面的监测方法,不仅仅是对皮肤癌的监测.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Cancers Originate from Somatic Mutations in a Single Cell
12.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.1K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


